TP53 and cancer: Although whether centrosome amplification is directly related to cancer remains unclear, several studies have observed that it promotes early-onset tumorigenesis in conditions of p53 deficiency5,6 or in the presence of wild-type p537, suggesting a close correlation between centrosome amplification and cancer development.